Xeris Biopharma (XERS)
Markets Recorlev, Gvoke and Keveyis while advancing formulation-based drug programs.
$8.73
After hours0.00 (0.00%)
At close$8.73(−0.80%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
$0.02
Revenue estimate
$101.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.03−$0.06−$0.01$0.00$0.06$0.01−$0.18Pending
Estimate−$0.08−$0.07−$0.03$0.01$0.03$0.00$0.01$0.02
Surprise+62.5%+14.3%+66.7%−65.0%+100.0%—−1,582.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$60.1M$60.1M$71.5M$74.4M$85.8M$82.5M$91.0MPending
Estimate$54.9M$57.6M$72.3M$86.0M$82.2M$79.8M$90.1M$101.6M
Surprise+9.5%+4.4%−1.0%−13.5%+4.4%+3.3%+1.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.14 | — | — |
| Sep 2028 | $0.12 | — | — |
| Jun 2028 | $0.08 | — | — |
| Mar 2028 | $0.09 | — | — |
| Dec 2027 | $0.15 | — | — |
| Sep 2027 | $0.10 | — | — |
| Jun 2027 | $0.07 | — | — |
| Mar 2027 | $0.05 | — | — |
| Dec 2026 | $0.05 | — | — |
| Nov 2026 | $0.02 | — | — |
| Aug 2026 | $0.01 | −$0.18 | −1,582.7% |
| May 2026 | $0.00 | $0.01 | — |
| Mar 2026 | $0.03 | $0.06 | +100.0% |
| Nov 2025 | $0.01 | $0.00 | −65.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Mar 2018 | |||
| Jun 2018 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.14 | — | — | $139.7M | — | — | — |
| Sep 2028 | $0.12 | — | — | $138.7M | — | — | — |
| Jun 2028 | $0.08 | — | — | $130.1M | — | — | — |
| Mar 2028 | $0.09 | — | — | $120.6M | — | — | — |
| Dec 2027 | $0.15 | — | — | $136.2M | — | — | — |
| Sep 2027 | $0.10 | — | — | $124.4M | — | — | — |
| Jun 2027 | $0.07 | — | — | $115.1M | — | — | — |
| Mar 2027 | $0.05 | — | — | $105.0M | — | — | — |
| Dec 2026 | $0.05 | — | — | $110.7M | — | — | — |
| Nov 5, 2026 | $0.02 | — | — | $101.6M | — | — | — |
| Aug 6, 2026 | $0.01 | −$0.18 | −1,582.7% | $90.1M | $91.0M | +1.0% | −9.3% |
| May 7, 2026 | $0.00 | $0.01 | — | $79.8M | $82.5M | +3.3% | +4.1% |
| Mar 2, 2026 | $0.03 | $0.06 | +100.0% | $82.2M | $85.8M | +4.4% | −1.6% |
| Nov 6, 2025 | $0.01 | $0.00 | −65.0% | $86.0M | $74.4M | −13.5% | −21.9% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 6, 2025 | |||||||
| Nov 8, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 6, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 8, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 10, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 9, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 11, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 6, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 13, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Jun 21, 2018 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |